{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/malaria/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"945266cc-cfef-5b4f-8052-2fd55963fc95","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 45626c07-5f59-4a24-8d29-076c27e4e612 --><h2>How should I assess a person with suspected malaria?</h2><!-- end field 45626c07-5f59-4a24-8d29-076c27e4e612 -->","summary":"","htmlStringContent":"<!-- begin item 553d589f-47eb-4943-ade4-8e4842020804 --><!-- begin field 70ac76d7-6caf-4361-bb76-9bd7aa4428de --><ul><li><strong>Take a history asking about:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/malaria/diagnosis/clinical-features/\">Symptoms of malaria</a> (such as fever, sweats, chills, malaise, myalgia, headache, vomiting, diarrhoea and cough) and timing of onset.</li><li>Travel history including:<ul><li>Country and area of travel.</li><li>Stopovers and other countries transited through.</li><li>Date of return.</li><li>Type of travel and activities while abroad — people returning from visiting friends and family in endemic areas are more at risk of malaria than tourists.</li></ul></li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/malaria/diagnosis/differential-diagnosis/\">differential diagnoses</a>:<ul><li>Immediately isolate anyone suspected of having a viral haemorrhagic fever (VHF) such as Ebola, Lassa fever or Marburg in a side room — further assessment must be in line with Public Health England guidelines on <a href=\"https://www.gov.uk/government/publications/viral-haemorrhagic-fever-algorithm-and-guidance-on-management-of-patients\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"5bfe7419-266a-4a5b-809d-a931009de890\">Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence</a>.</li></ul></li><li>Preventative measures such as:<ul><li>Malaria chemoprophylaxis (drug, dose, adherence and cessation) — full adherence to appropriate prophylaxis does not guarantee protection against malaria.</li><li>Precautions taken against biting insects for example insecticide-impregnated bednets and repellent.</li><li>Travel immunisations against other travel related infections such as yellow fever.</li></ul></li><li>Risk of severe malaria:<ul><li>Severe malaria is more likely in children, pregnant women, older people, and immunocompromised people (for example those with splenectomy or HIV/AIDS).</li></ul></li></ul></li><li><strong>Examine the person, looking for:</strong><ul><li>Signs of <a class=\"topic-reference internal-reference\" href=\"/topics/malaria/diagnosis/clinical-features/\">severe malaria</a> such as impaired consciousness, confusion, hypotension, respiratory distress or jaundice.<ul><li>Check vital signs such as blood pressure, pulse, temperature (fever may not be present), respiration rate and oxygen saturation.</li><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/malaria/background-information/complications/#glasgow-blantyre-coma-score\">Glasgow and Blantyre coma scales</a> can be used to assess level of consciousness.</li></ul></li><li>Pallor — suggestive of anaemia.</li><li>Hepatomegaly or splenomegaly.</li></ul></li><li><strong>Arrange appropriate investigations:</strong><ul><li>Malaria is a medical emergency and if suspected, a blood test to confirm the diagnosis must be carried out without delay.</li><li>Diagnosis of malaria is only possible with microscopy of thick and thin blood films (the gold standard) or an antigen detection test.<ul><li>Most people will need immediate referral to secondary care (an Infectious Disease or appropriate Medical Assessment Unit) to allow prompt testing.</li><li>If the person is well and local facilities can ensure return of a result to the requesting doctor within 2 hours, testing may be carried out from primary care after discussion with an Infectious Disease specialist.</li><li>EDTA should be used for blood samples.</li><li>If the first blood films are negative, further blood testing must be arranged 12 to 24 hours later and again after a further 24 hours to rule out infection.</li><li>In pregnancy, thick films can be negative, despite the presence of parasites in the placenta. Expert advice should always be sought if malaria is suspected.</li></ul></li></ul></li></ul><!-- end field 70ac76d7-6caf-4361-bb76-9bd7aa4428de --><!-- end item 553d589f-47eb-4943-ade4-8e4842020804 -->","topic":{"id":"a45cc869-8a29-5718-8d8c-fb4da11e3f58","topicId":"396f54ea-4a43-432a-964a-bf1c1d1ec304","topicName":"Malaria","slug":"malaria","lastRevised":"Last revised in November 2017","chapters":[{"id":"77ca73e7-67fc-5532-afdd-8a33d4f624bc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1d13888f-5984-5ba7-b602-28290217579c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"47353782-3c00-592f-bb46-5aed457f620b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c79fc9bf-9bf2-5be3-96a4-0e3a7b6c035d","slug":"changes","fullItemName":"Changes"},{"id":"170e13bf-3ada-54b4-b1da-bf3f2e576eff","slug":"update","fullItemName":"Update"}]},{"id":"edb18b0f-ecf6-511d-a62e-1a7193478cf6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e59bc905-80b7-59af-bcf3-18c542a8d661","slug":"goals","fullItemName":"Goals"},{"id":"016d9462-dbe7-5825-a4d6-41fc5e8d1de3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"712ad264-c3b5-5462-be1e-e09e84881fdd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"641a2f83-4b03-5455-8d1f-6d262c88ef45","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"beeed4d8-0061-5d53-9a52-4d9334fb0910","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4ec1d6f-3615-57b6-ae2a-adb55e52ea5d","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"b057ab2c-b9ca-5c35-835c-b6eae8d2496a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"498a864c-c278-5bde-b72a-027b19ecbc6e","slug":"definition","fullItemName":"Definition"},{"id":"13d57b0c-a8e8-5545-96f7-ee1a1c63e32a","slug":"causes","fullItemName":"Causes"},{"id":"866f277b-df2d-578d-b7d7-3a177101a324","slug":"prevalence","fullItemName":"Prevalence"},{"id":"706cfee4-7e61-51db-a06e-70897a85bb03","slug":"prognosis","fullItemName":"Prognosis"},{"id":"e7fbe927-f840-59a4-8e00-106c2834620c","slug":"complications","fullItemName":"Complications"}]},{"id":"0f19cdf2-1ae3-59f9-aa7e-5c62ccf99e0b","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"626cfe9a-1cdd-5ce1-b17e-aa5e34dfd463","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"945266cc-cfef-5b4f-8052-2fd55963fc95","slug":"assessment","fullItemName":"Assessment"},{"id":"8001a16a-f444-515d-868e-29a0fb3d528b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f44c57a5-21c7-5020-af41-0c1bce84d4fb","fullItemName":"Management","slug":"management","subChapters":[{"id":"1e63a1a0-efe4-5864-b436-fdab0190793f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"9fb3ee06-d5b5-5f13-91bd-eb4f5b931651","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bcaaf29e-dba5-5a1d-95af-f33c4cb8b1ab","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3a06d73b-b4d8-540e-b662-f35a7a79658a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26a9dace-bd47-561a-99a4-80a39ae3a7fc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"13eeb1d8-0198-54d8-92a2-1af0e30acbef","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7184569b-0bd0-580e-94f2-74fa8726805c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"724d6a34-a291-5477-a333-21be291a07cb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ed00be2d-b5e0-51b5-ade1-2acfd1171a2b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0f19cdf2-1ae3-59f9-aa7e-5c62ccf99e0b","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"577bf50b-ca33-53f8-94dc-34a8a809ed69","slug":"basis-for-recommendation-a22","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 42e1572f-32b9-4394-afca-dc4bcdbee038 --><h3>Basis for recommendation</h3><!-- end field 42e1572f-32b9-4394-afca-dc4bcdbee038 -->","summary":null,"htmlStringContent":"<!-- begin item a22ef29a-b0b8-45bc-af79-be49f29dc25f --><!-- begin field d351517a-2409-4cf3-bf06-31567b11cae1 --><p>The recommendations on how to assess a person with suspected malaria are based on the clinical guidelines <em>Management of imported malaria in Europe</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">ESCMID, 2012</a>], <em>G</em><em>uidelines for the treatment of malaria</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">WHO, 2015</a>], <em>The Yellow Book: Chapter 5: General approach to the returned traveller. Fever in returned travellers</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">CDC, 2016b</a>], <em>U</em><em>K malaria treatment guidelines 2016</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>], <em>Malaria reference laboratory: user handbook (August 2016)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHE, 2016b</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Johnston et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Bell, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Bailey, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Feder, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Whitty, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Willcox, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">BMJ Best Practice, 2016</a>].</p><h4>Blood films are essential to confirm a diagnosis of malaria</h4><ul><li>Blood films are needed to identify the causative Plasmodium species and parasite density — these have important implications for prognosis and treatment decisions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Whitty, 2013</a>].</li></ul><h4>Most people should immediately be referred to secondary care for investigation</h4><ul><li>Unless rapid malaria testing is available in primary care, all people with suspected malaria should be referred to secondary care for testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].<ul><li>The results of parasitological testing should be available within 2 hours of the person presenting [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">WHO, 2015</a>].</li><li>Blood films should be made as soon as possible (at most within 2 hours) from EDTA samples to minimise morphological changes in the parasites [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Bailey, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHE, 2016b</a>].</li></ul></li><li>If malaria is suspected, general practitioners should liaise with an Infectious Disease specialist or the medical registrar to arrange assessment of the person patient in an Infectious Diseases Unit or appropriate Medical Assessment Unit. “It is unlikely that blood samples would be sent from General Practice, due to the time delay that this would incur” [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">NIHR, 2015</a>].</li><li>If <em>P. malariae</em> is suspected in a person returning from travel in South-East Asia, urgent referral should be made to the Malaria Reference Laboratory to exclude <em>P. knowlesi</em> infections as these two species are difficult to distinguish by morphology and <em>P. knowlesi</em> can rapidly cause severe or fatal malaria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Johnston et al, 2009</a>].</li></ul><h4>Repeat blood films are needed if the first is negative</h4><ul><li>Diagnosis can only be excluded when three negative diagnostic samples over a period of 24–48 hours are available [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul><!-- end field d351517a-2409-4cf3-bf06-31567b11cae1 --><!-- end item a22ef29a-b0b8-45bc-af79-be49f29dc25f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}